Vor Biopharma

OverviewSuggest Edit

Vor Biopharma is a biopharmaceutical company developing novel therapies with potential for treating cancer. The Company has developed a health and safety commission technology platform to address the limitations of the immunotherapies, including antibody-drug conjugates, bispecific antibodies, and chimeric antigen receptor T cells.

HQBoston, US

Recent NewsAll News

Latest Updates

Employees (est.) (Feb 2019)5

Vor Biopharma Office Locations

Vor Biopharma has an office in Boston
Boston, US (HQ)
501 Boylston St #6102
Show all (1)

Vor Biopharma Financials and Metrics

Summary Metrics

Founding Date


Vor Biopharma total Funding

$42 m

Vor Biopharma latest funding size

$42 m

Time since last funding

8 months ago

Vor Biopharma investors

Vor Biopharma's latest funding round in February 2019 was reported to be $42 m. In total, Vor Biopharma has raised $42 m
Show all financial metrics

Vor Biopharma Online and Social Media Presence

Embed Graph

Vor Biopharma News and Updates

VC-backed Vor Biopharma appoints president/CEO

Cambridge, Massachusetts-based Vor Biopharma, an oncology company, has named Dr. Robert Ang as president and CEO. Ang is the former chief business officer of Neon Therapeutics. Vor Biopharma's backers include 5AM Ventures, RA Capital Management and Johnson & Johnson Innovation – JJDC Inc.

Vor Biopharma Frequently Asked Questions

  • When was Vor Biopharma founded?

    Vor Biopharma was founded in 2016.

  • How many employees does Vor Biopharma have?

    Vor Biopharma has 5 employees.

  • Who are Vor Biopharma competitors?

    Competitors of Vor Biopharma include NextCure, Actuate Therapeutics and Celgene.

  • Where is Vor Biopharma headquarters?

    Vor Biopharma headquarters is located at 501 Boylston St #6102, Boston.

  • Where are Vor Biopharma offices?

    Vor Biopharma has an office in Boston.

  • How many offices does Vor Biopharma have?

    Vor Biopharma has 1 office.